Epstein Secrets

ontact your J.P. Morgan team for additional information. ** Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC FACEBOOK INC-A 04033A-10-0 ARIA 146.59 09062X-10-3 BIIB 18.06 30303M-10-2 FB GS CONT BUFF EQ SPX 7/9/13 80% CONTIN BARRIER- 10.5%CPN 15% CAP INITIAL LEVEL-

me ALLY FINANCIAL INC 24.54 8 1/2% PFD 02005N-30-8 NA /CAA ROYAL BANK SCOTLAND GRP PLC 5.05% JAN 08 2015 DTD 12/08/2004 780097-AP-6 BB+ /BA3 HCA INC 6 1/2% FEB 15 2016 DTD 2/8/2006 404119-AR-0 B- /B3 CIT GROUP INC 144A 7% MAY 02 2016 JUN 15 2011 125581-FZ-6 BB- /B1 AMERICAN AXLE & MFG INC 7

. Morgan team for additional information. ** Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC DEAN FOODS CO FACEBOOK INC-A 04033A-10-0 ARIA 146.37 09062X-10-3 BIIB 16.51 242370-10-4 DF 26.62 30303M-10-2 FB Total US Large Cap Equity $1,502,386.45 $1,637,370.22 (

Quantity Value Adjusted Tax Cost Original Cost Unrealized Gain/Loss Est. Annual Income Accrued Interest Yield $0.00 0.00% US Fixed Income HCA INC 108.50 6 1/2% FEB 15 2016 DTD 2/8/2006 404119-AR-0 B- /B3 AMERICAN AXLE & MFG INC 7 7/8% MAR 1 2017 DTD 2/27/2007 02406P-AF-7 B /B2 NRG ENER

se contact your J.P. Morgan team for additional information. Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC FACEBOOK INC-A 04033A-10-0 ARIA 149.21 09062X-10-3 BIIB 21.66 30303M-10-2 FB Total US Large Cap Equity $1,091,957.30 $1,166,930.47 ($74,973.17) $0.00 0.0

IAL INC 24.46 8 1/2% PFD 02005N-30-8 NA /CAA ROYAL BANK SCOTLAND GRP PLC 5.05% JAN 08 2015 DTD 12/08/2004 EFTA01540070 780097-AP-6 BB+ /BA3 HCA INC 6 1/2% FEB 15 2016 DTD 2/8/2006 404119-AR-0 B- /B3 AMERICAN AXLE & MFG INC 7 7/8% MAR 1 2017 DTD 2/27/2007 02406P-AF-7 B /B2 Account W23560001

-10-0 ARIA 144.38 09062X-10-3 BIIB DB CONT BUFF EQ MS 08/07/12 25% CONTIN BARRIER- 13%CPN 30% CAP INITIAL LEVEL-07/15/11 MS:21.09 2515A1-A7-6 FACEBOOK INC-A 30303M-10-2 FB GS CONT BUFF EQ SPX 7/9/13 80% CONTIN BARRIER- 10.5%CPN 15% CAP INITIAL LEVEL-6/20/12 SPX:1355.69 38143U-Z9-5 HSBC MARKET PLUS

ITAL LTD 8.96% DEC 31 2013 DTD 06/28/2010 02503Y-AF-0 B /NA ROYAL BANK SCOTLAND GRP PLC 5.05% JAN 08 2015 DTD 12/08/2004 780097-AP-6 BB+ /BA3 HCA INC 6 1/2% FEB 15 2016 DTD 2/8/2006 404119-AR-0 B- /B3 CIT GROUP INC 144A 7% MAY 02 2016 JUN 15 2011 125581-FZ-6 BB- /B1 EFTA01539790 100.25 5,0

-10-0 ARIA 145.83 09062X-10-3 BIIB DB CONT BUFF EQ MS 08/07/12 25% CONTIN BARRIER- 13%CPN 30% CAP INITIAL LEVEL-07/15/11 MS:21.09 2515A1-A7-6 FACEBOOK INC-A 30303M-10-2 FB GS CONT BUFF EQ SPX 7/9/13 80% CONTIN BARRIER- 10.5%CPN 15% CAP INITIAL LEVEL-6/20/12 SPX:1355.69 38143U-Z9-5 HSBC MARKET PLUS

ITAL LTD 8.96% DEC 31 2013 DTD 06/28/2010 02503Y-AF-0 B /NR ROYAL BANK SCOTLAND GRP PLC 5.05% JAN 08 2015 DTD 12/08/2004 780097-AP-6 BB+ /BA3 HCA INC 6 1/2% FEB 15 2016 DTD 2/8/2006 404119-AR-0 B- /B3 CIT GROUP INC 144A 7% MAY 02 2016 JUN 15 2011 125581-FZ-6 BB- /B1 EFTA01539886 100.57 5,0

. Morgan team for additional information. ** Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC DEAN FOODS CO FACEBOOK INC-A 04033A-10-0 ARIA 149.09 09062X-10-3 BIIB 17.14 242370-10-4 DF 28.00 30303M-10-2 FB Total US Large Cap Equity $1,600,566.15 $1,637,370.22 (

1.30 0.01 0.01 837,388.58 1,089,106.75 $1,089,106.76 0.01 1,076,801.61 $1,076,801.62 12,305.14 $12,305.14 $0.00 0.00% US Fixed Income HCA INC 107.75 6 1/2% FEB 15 2016 DTD 2/8/2006 404119-AR-0 B- /B3 AMERICAN AXLE & MFG INC 7 7/8% MAR 1 2017 DTD 2/27/2007 02406P-AF-7 B /B2 NRG ENER

J.P. Morgan team for additional information. Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC DEAN FOODS CO FACEBOOK INC-A 04033A-10-0 ARIA 138.21 09062X-10-3 BIIB 16.84 242370-10-4 DF 21.11 30303M-10-2 FB Total US Large Cap Equity $1,436,308.39 $1,637,370.22 (

1 1,098,655.02 $1,098,655.03 (13,567.74) ($13,567.74) $0.00 0.00% US Fixed Income ALLY FINANCIAL INC 25.05 8 1/2% PFD 02005N-30-8 NA /CAA HCA INC 6 1/2% FEB 15 2016 DTD 2/8/2006 EFTA01540169 404119-AR-0 B- /B3 AMERICAN AXLE & MFG INC 7 7/8% MAR 1 2017 DTD 2/27/2007 02406P-AF-7 B /B2 NRG